Trial intelligence / Profile preview

Carboprost plus tourniquet versus tourniquet alone during abdominal myomectomy

PACTR202602858892247Recruiting

Sponsor
Metropolitan Health Insurance Ghana
Start
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of carboprost in Fibromyoma (LM), sponsored by Metropolitan Health Insurance Ghana. Started Feb 2026; status: recruiting.

02

Drugs

carboprost
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on PACTR202602858892247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202602858892247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call